Neutrogena contributes to 5% gain in J&J worldwide consumer sales in second quarter.
This article was originally published in The Rose Sheet
NEUTROGENA CONTRIBUTES TO 5% SALES GAIN IN J&J CONSUMER SALES during the second quarter, Johnson & Johnson reported July 16. Sales for the consumer group reached $1.54 bil., led by the Neutrogena adult skin and hair care products, the recently launched Pepcid AC heartburn remedy and Tylenol analgesics, according to the company. In April, J&J's Neutrogena group introduced a line of "Renova compatible" skin care products with a print ad campaign running in professional publications ("The Rose Sheet" Jan. 22, p. 8)
You may also be interested in...
PD-1/PDL-1 inhibitors have not proved effective for ovarian cancer on their own or in combinations. Now Roche's Tecentriq, combined with the firm's blockbuster Avastin, has suffered a similar fate to Merck KGaA and Pfizer's Bavencio in failing to improve survival.
Increased uptake for generics and biosimilars must become Belgium’s “new normal” in the wake of the coronavirus crisis, local off-patent industry association Medaxes has argued.
Although biological medicines carry a very low risk of being contaminated by nitrosamine impurities, the EMA says the possibility cannot be ruled out.